Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
PHILADELPHIA--(BUSINESS WIRE)--In patients with symptomatic asthma despite at least ICS/LABA therapy, tiotropium delivered by the Respimat® SoftMistTM Inhaler increases time to first severe exacerbation and first episode of asthma worsening. This improvement is independent of age, allergic status, smoking status and bronchodilator response.1
Help employers find you! Check out all the jobs and post your resume.
PHILADELPHIA--(BUSINESS WIRE)--In patients with symptomatic asthma despite at least ICS/LABA therapy, tiotropium delivered by the Respimat® SoftMistTM Inhaler increases time to first severe exacerbation and first episode of asthma worsening. This improvement is independent of age, allergic status, smoking status and bronchodilator response.1
Help employers find you! Check out all the jobs and post your resume.
